SpaceX's Bond Sale: A Strategic Move Amidst Massive Cash Reserves
SpaceX's recent bond sale comes as it holds $100.8 billion in cash, reflecting strategic capital market positioning.
AbbVie’s $10.9 Billion Bet on Apogee: What It Means for Investors
AbbVie's $10.9 billion acquisition of Apogee Therapeutics reshapes its pipeline and reflects broader M&A trends in pharma.
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.
CDT Equity's 45.93% Surge: Understanding the Catalysts Behind the Rally
Exploring the factors driving CDT Equity's recent surge and the implications for traders in the critical minerals sector…
CRH's $8 Billion Acquisition of Arcosa: A Major Infrastructure Move
CRH's potential $8 billion acquisition of Arcosa could reshape the construction materials sector significantly.
Analyst Upgrade: Incyte Stock's New Market Perform Rating
BMO Capital's upgrade of Incyte to Market Perform reflects strategic progress but may pose risks for investors.
REGENXBIO's Path Forward: FDA Alignment on Gene Therapy Resubmission
REGENXBIO aligns with the FDA on gene therapy resubmission, paving the way for NAVSUNLI's future.
AbbVie's Strategic Bet: The $10.9 Billion Acquisition of Apogee Therapeutics
AbbVie is set to acquire Apogee Therapeutics for $10.9 billion, signaling a strategic move in the immunology sector.
SpaceX's Bond Offering: A Landmark Move in US Capital Markets
SpaceX's bond offering signals a significant shift in investor sentiment and market expectations.
BMO Capital Upgrades Incyte: A Sign of Renewed Confidence
BMO Capital's upgrade of Incyte (INCY) signals confidence in the company's strategic direction and potential investor op…
Prime Medicine's PM359 Lands FDA RMAT Designation: What It Means for Gene Therapy
Prime Medicine ($PRME) secures FDA RMAT status for PM359 in CGD treatment, signaling accelerated development path and po…
REGENXBIO’s FDA Alignment: A Positive Step for NAVSUNLI Gene Therapy
REGENXBIO's alignment with the FDA on NAVSUNLI could influence investor sentiment and future share performance.